Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 2 de 2
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 42(9): 831-838, Sept. 2009. ilus, tab
Article Dans Anglais | LILACS | ID: lil-524314

Résumé

Our objective was to determine whether the presence of the human leukocyte antigen HLA-DRB1 locus is associated with production of anti-cyclic citrullinated peptide antibodies (anti-CCP Abs) and to what extent they are associated with increased susceptibility to and severity of rheumatoid arthritis (RA) in Egyptian patients. Twenty-nine RA patients gave informed consent to participate in a case-control study that was approved by the Ain Shams University Medical Ethics Committee. RA disease activity and severity were determined using the simplified disease activity index and Larsen scores, respectively. We used a wide scale national study on the pattern of HLA typing in normal Egyptians as a control study. Anti-CCP Abs and HLA-DRB1 typing were determined for all subjects. The alleles most strongly associated with RA were HLA-DRB1 [*01 , *04 and *06] (41.4 percent). RA patients with serum anti-CCP Ab titers above 60 U/mL had a significantly higher frequency of HLA-DRB1*01 (58.3 percent) and HLA-DRB1*04 alleles (83.3 percent). Significant positive correlations were found between serum and synovial anti-CCP Ab titer, RA disease activity, and severity (r = 0.87, 0.66 and 0.63, respectively; P < 0.05). HLA-DRB1 SE+ alleles [*01 and *04] were highly expressed among Egyptian RA patients. The presence of these alleles was associated with higher anti-CCP Ab titer, active and severe RA disease. Early determination of HLA-DRB1 SE+ alleles and serum anti-CCP Ab could facilitate the prediction of the clinical course and prognosis of RA when first evaluated leading to better disease control.


Sujets)
Adulte , Femelle , Humains , Polyarthrite rhumatoïde/immunologie , Autoanticorps/sang , Antigènes HLA-DR/génétique , Peptides cycliques/génétique , Polyarthrite rhumatoïde/sang , Autoanticorps/génétique , Autoanticorps/immunologie , Études cas-témoins , Égypte , Électrophorèse sur gel d'agar , Fréquence d'allèle , Prédisposition génétique à une maladie , Génotype , Peptides cycliques/immunologie , Indice de gravité de la maladie
2.
Middle East Journal of Anesthesiology. 2003; 17 (3): 415-426
Dans Anglais | IMEMR | ID: emr-63941

Résumé

Addition of fentanyl to hyperbaric bupivacaine spinal anesthesia prolonged the duration of sensory block. This study seeks to test the hypothesis that adding fentanyl to small dose hypobaric spinal anesthesia will improve intraoperative patients and surgeon satisfaction without delay in recovery. Patients [n = 80] subjected to minor cystoscopic surgery were randomly assigned to have spinal anesthesia with either 5mg bupivacaine 0.1% or 5mg bupivacaine 0.1% mixed with 20microg fentanyl. The main outcome measures included intraoperative patient and endoscopist satisfaction, sedative/analgesic supplementation, postoperative side effects and time to ambulation. Patients in the bupivacaine group needed more analgesic supplementation. Analgesia was more adequate in the bupivacaine-fentaynl group. Pruritus was the main side effect in the bupivacaine fentanyl group. Ambulation and discharge of patients were nearly the same in both groups. Conclusions: Spinal anesthesia with small dose [5mg] hypobaric [0.1%] bupivacaine mixed with fentanyl [20micro g] produced adequate anesthesia for short cystoscopic procedures with minimal side effects and without delay in ambulation


Sujets)
Humains , Mâle , Bupivacaïne/pharmacologie , Fentanyl/pharmacologie , Cystoscopie
SÉLECTION CITATIONS
Détails de la recherche